Ron Alfa | Vice President of Discovery and Product
Recursion Pharmaceuticals

Ron Alfa, Vice President of Discovery and Product, Recursion Pharmaceuticals

Ron holds an MD and a PhD (Neurosciences) from Stanford University and an MA from University College London. Over the course of his education, he has developed molecular therapeutics for Alzheimer's disease, discovered hormones of metabolism, and puzzled over the basis of the placebo effect. A California native, he traded the Valley for the Slopes to follow his passion for accelerating therapeutic discovery with Recursion. When he's not working, Ron enjoys taking on various projects which some might construe as questionably different from working.


World Orphan Drug Congress USA 2018 - Conference Day Two @ 15:10

The value of computer vision, machine learning and robotic automation to expedite rare disease research

  • Running experiments and performing analysis on hundreds of diseases simultaneously using powerful software and analytics
  • Finding new indications for existing drugs using augmented high-throughput drug research and technology
  • Creating high-resolution, comprehensive biological data sets 
  • Academia-industry partnerships to foster rare disease research

back to speakers